Angiotensin II (Ang II) infusion into ApoE−/− mice augments atherosclerotic plaque and abdominal aortic aneurysm (AAA) formation [1], via mechanisms causing increased monocyte-macrophage recruitment and vascular wall remodeling. The gene discussed is AGT; the disease is triple-A syndrome.